Eli Lilly & Co. has made significant strides in resolving the shortage of its prominent diabetes and weight-loss drugs, Mounjaro and Zepbound, in the United States. This development has crucial implications for the growing market for compounded medications—often seen as cheaper alternatives to brand-name drugs. As the United States Food and Drug Administration (FDA) confirmed […]
Global Connectivity Takes Center Stage at the IGF 2024 in Riyadh
The Internet Governance Forum (IGF) 2024, held in Riyadh, has emerged as a pivotal event in reinforcing the importance of global connectivity. With discussions centered around various facets of connectivity, attendees highlighted its critical role in accessing healthcare, education, and economic opportunities, underscoring that in today’s digital landscape, connection is not merely a convenience but […]
Hims Drops Most Ever as Amazon Enters Hair-Loss Drug Market
The recent move by Amazon to market hair-loss treatments has sent shockwaves through the telehealth sector, particularly affecting Hims & Hers Health Inc. The company’s shares plummeted by 18 percent—marking the steepest decline in its five-year trading history—on the announcement of Amazon’s entry into this lucrative market. This turn of events underscores the intense competition […]